| Sample | Title | Value | Rank |
|---|
| GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.30147 | 95 |
| GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.15101 | 94 |
| GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.30138 | 94 |
| GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.27478 | 94 |
| GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.31104 | 94 |
| GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.35529 | 95 |
| GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.15922 | 95 |
| GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.15244 | 94 |
| GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.18795 | 94 |
| GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.26613 | 94 |
| GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.48678 | 95 |
| GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.26327 | 94 |
| GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.386 | 95 |
| GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.31055 | 95 |